Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / EcoR1 Capital, LLC
Form 13F · Q2 2026

EcoR1 Capital, LLC

CIK 1587114申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$20.6亿
申报组合市值
33
持仓数量
12
Quarters on record
Top 50
持仓数量

EcoR1 Capital, LLC——持仓

共 33 个持仓中的前 31 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1ZYME Zymeworks Inc23.0M+0.0%$6.0亿29.2%
2ANAB Anaptysbio Inc7.9M+0.0%$5.3亿25.9%
3AKTS Aktis Oncology Inc4.8M+0.0%$1.6亿7.6%
4CGON Cg Oncology Inc1.5M+35.6%$1.1亿5.2%
5ETON Eton Pharmaceuticals Inc2.2M+0.0%$7862万3.8%
6CRSP Crispr Therapeutics Ag1.4M+0.0%$7577万3.7%
7ORIC Oric Pharmaceuticals Inc6.7M+0.0%$7287万3.5%
8TRAX First Tracks Biotherapeutics3.2M—$6387万3.1%
9LKFT Lakefront Biotherapeutics1.7M+0.0%$4998万2.4%
10NGNE Neurogene Inc1.3M+0.0%$3998万1.9%
11STOK Stoke Therapeutics Inc735,000+635.0%$2405万1.2%
12FULC Fulcrum Therapeutics Inc6.5M—$2397万1.2%
13LEGN Legend Biotech Corp800,000—$2310万1.1%
14BBOT Bridgebio Oncology Therapeut2.8M+0.0%$2151万1.0%
15MBX Mbx Biosciences Inc388,500−50.0%$2145万1.0%
16ZBIO Zenas Biopharma Inc789,500+0.0%$2004万1.0%
17ATRA Atara Biotherapeutics Inc1.6M+1458.3%$1782万0.9%
18RLAY Relay Therapeutics Inc697,948−63.4%$1306万0.6%
19AURA Aura Biosciences Inc1.7M—$1183万0.6%
20ODTX Odyssey Therapeutics Inc555,555—$1039万0.5%
21EIKN Eikon Therapeutics Inc732,606+0.0%$956万0.5%
22PHVS Pharvaris N V235,000—$813万0.4%
23ZURA Zura Bio Ltd1.2M+0.0%$696万0.3%
24PHAT Phathom Pharmaceuticals Inc625,000+0.0%$678万0.3%
25NRIX Nurix Therapeutics Inc270,000—$655万0.3%
26ERAS Erasca Inc330,000−63.3%$605万0.3%
27ELOX Eloxx Pharmaceuticals Inc400,000—$555万0.3%
28AARD Aardvark Therapeutics Inc396,194—$228万0.1%
29HLXC Helix Acquisition Corp Iii200,000+0.0%$213万0.1%
30MREO Mereo Biopharma Group Plc1.0M−92.5%$32万0.0%
31SRZN Surrozen Inc4,444+0.0%$12万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。